| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $72K | +0.0% |
| Cost of Revenue | $44K | +658.7% |
| Gross Profit | $28K | -58.0% |
| R&D Expense | $2.2M | -8.8% |
| SG&A Expense | $4.3M | -9.7% |
| Operating Income | -$4.3M | +9.0% |
| Pre-tax Income | -$4.2M | +3.8% |
| Net Income | -$4.2M | +3.8% |
| EPS (Basic) | -$0.50 | +58.0% |
| EPS (Diluted) | -$0.50 | +58.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.7M | +21.6% |
| Short-term Investments | $2.1M | -33.5% |
| Current Assets | $7.4M | +3.9% |
| Total Assets | $7.6M | +2.6% |
| Current Liabilities | $650K | -60.7% |
| Total Liabilities | $1.3M | -45.3% |
| Stockholders' Equity | $6.3M | +25.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.7M | -21.6% |
| Investing Cash Flow | $644K | -33.9% |
| Financing Cash Flow | $4.9M | +49.9% |